Delivery Order SPE2DB24D2205-SPE2DB25FDSVA

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,210 units of the medication Carvedilol ER 20 mg capsules. The contract has a ceiling value of $2,769.87 and a period of performance through October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566599978 units of the drug carvedilol ER 20 mg capsules. The $21,226.09 firm fixed-price contract was awarded on December 3, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $7,055.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,736,782 units of the medication Carvedilol ER 20 mg capsules in 30-count packages. This contract is a delivery order, with a firm fixed price, and has an ultimate completion date of December 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,750,853 units of the drug carvedilol ER 20 mg capsules. The contract is a Firm Fixed Price Delivery Order valued at $9,155.47, with a period of performance through April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award, valued at $3,097.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Carvedilol ER 20 mg capsules, a cardiovascular medication, with a performance period ending on December 30, 2024. The contract is structured as a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.28 delivery order contract is for the supply of 4,567,916,245 units of the prescription medication Carvedilol ER 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This federal contract award, valued at $1,738.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Carvedilol ER 20 mg capsules, a cardiovascular medication, with a completion date of October 23, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,538.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 20 mg capsules, a medication used for cardiovascular health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,280.47, is for the delivery of 4,567,956,736 units of the medication Carvedilol ER 40 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 18, 2025. This award is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The $17,626.91 firm fixed-price contract has a completion date of June 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSVA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,134,894 units of the medication Carvedilol ER 20 mg capsules. The contract, valued at $24,534.64, is a firm fixed-price delivery order with an ultimate completion date of October 18, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, and there is no indication of any set-aside requirements.

The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 1/16/25, 9:33 AM